Earnings › Johnson & Johnson · Johnson & Johnson company page · insider trades
Johnson & Johnson earnings
Johnson & Johnson (JNJ) quarterly revenue, net income and diluted EPS from its SEC filings, the upcoming report date, and links to each earnings release. Last update 2026-10-14.
Johnson & Johnson reports Q3 2026 results, raises 2026 guidance(Johnson & Johnson press release headline)
Press release (Ex. 99.1) ↗ · 8-K filing on SEC EDGAR ↗
The quarterly table below fills in this quarter when Johnson & Johnson files its 10-Q or 10-K with XBRL data.
Subscribe to Johnson & Johnson earnings dates in your calendar app (updates automatically)
Also reporting around the same time
- Goldman Sachs · Oct 13, 2026
- JPMorgan Chase · Oct 13, 2026
- UnitedHealth · Oct 13, 2026
- Wells Fargo · Oct 13, 2026
- Bank of America · Oct 14, 2026
- BlackRock · Oct 14, 2026
- Morgan Stanley · Oct 14, 2026
- Charles Schwab · Oct 15, 2026
Quarterly results
| Quarter | Revenue | YoY | Net income | YoY | Diluted EPS |
|---|---|---|---|---|---|
| Q2 fiscal 2027 ended Jun 28, 2026 | $25.31B | +7% | $5.53B | −0% | $2.27 |
| Q1 fiscal 2027 ended Mar 29, 2026 | $24.06B | +10% | $5.24B | −52% | $2.14 |
| Q4 fiscal 2026 ended Dec 28, 2025 · from annual report | $24.56B | +9% | $5.12B | +49% | — |
| Q3 fiscal 2026 ended Sep 28, 2025 | $23.99B | +7% | $5.15B | +91% | $2.12 |
| Q2 fiscal 2026 ended Jun 29, 2025 | $23.74B | — | $5.54B | — | $2.29 |
| Q1 fiscal 2026 ended Mar 30, 2025 | $21.89B | — | $11.00B | — | $4.54 |
| Q4 fiscal 2025 ended Dec 29, 2024 · from annual report | $22.52B | — | $3.43B | — | — |
| Q3 fiscal 2025 ended Sep 29, 2024 | $22.47B | — | $2.69B | — | $1.11 |
Earnings releases (Form 8-K, Item 2.02)
- Oct 13, 2026: 8-K filing and press release ↗ ·
Johnson & Johnson reports Q3 2026 results, raises 2026 guidance
- Jul 15, 2026: 8-K filing and press release ↗
- Apr 14, 2026: 8-K filing and press release ↗
- Jan 21, 2026: 8-K filing and press release ↗
- Oct 14, 2025: 8-K filing and press release ↗
- Jul 16, 2025: 8-K filing and press release ↗
- Apr 15, 2025: 8-K filing and press release ↗
- Jan 22, 2025: 8-K filing and press release ↗
Source: SEC EDGAR XBRL company facts (10-Q and 10-K) and 8-K filings. Quarters marked "from annual report" are the annual total minus the three reported quarters, because Johnson & Johnson reports its fourth quarter only inside the annual report; EPS is not derived for those quarters. Figures are as reported under US GAAP. Not investment advice.
FAQ
Q When did Johnson & Johnson report third-quarter results results?
A Johnson & Johnson released third-quarter results results on Tuesday, Oct 13, 2026, in a press release filed with the SEC on Form 8-K.
Q What were Johnson & Johnson's latest quarterly results?
A For Q2 fiscal 2027 (ended Jun 28, 2026), Johnson & Johnson reported revenue of $25.31B and net income of $5.53B, or $2.27 per diluted share, according to its 10-Q filed Jul 23, 2026.